Immune response to pandemische influenza A/H1N1 vaccination in the immunocompromised.

Phase 4

Completed

• Conditions: flu; influenza; 10047438

• Registration Number: NL-OMON32477
• Lead Sponsor: eids Universitair Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 12 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 195

Inclusion Criteria

-

Exclusion Criteria

-

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>-</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>-</p><br>